Shire Receives European Approval for TAKHZYRO (lanadelumab) subcutaneous injection for the Preventive Treatment of Hereditary Angioedema
Shire plc the leading global biotechnology company focused on rare diseases, announced that the European Commission (EC) has granted Marketing...